BD Newsroom - News and media
WEB3 days ago · Connor Bates Named President of BD Medication Management Solutions. FRANKLIN LAKES, N.J. (Oct. 1, 2024) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Connor Bates has been named worldwide... Read More.
Press releases - BD Newsroom
WEB4 days ago · BD Names Michael Feld as President of Life Sciences Segment. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michael Feld has been named executive vice president and president of the Life... Show. 10. per page.
BD Completes Acquisition of Critical Care from Edwards Lifesciences
WEBSep 3, 2024 · BD Completes Acquisition of Critical Care from Edwards Lifesciences. Expands BD's portfolio of smart connected care solutions with leading monitoring technologies, including advanced AI-enabled clinical decision tools.
BD Receives FDA 510 (k) Clearance for Updated BD Alaris™ …
WEBJul 21, 2023 · This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring and auto-identification modules. It also covers a new BD Alaris™ Infusion System software version with enhanced …
BD to Highlight Progress Against BD 2025 Strategy and ... - BD …
WEBNov 12, 2021 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
BD Announces Completion of Embecta Corp. Spinoff
WEBMar 22, 2022 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which...
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD ... - BD …
WEBJul 24, 2023 · BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
BD Completes Bard Acquisition, Creating New Global Health
WEBDec 29, 2017 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health...
BD Initiates International Study to Expand Treatment Options for ...
WEBMar 4, 2024 · According to BD, the global, prospective, multi-center, single-arm, non-randomized AGILITY clinical study will include 315 patients at up to 40 clinical study sites across the United States, Europe, Australia and New Zealand.
BD to Invest $65 Million for Key Supply Chain ... - BD Newsroom
WEBApr 1, 2021 · BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona...